Hasan Uludag, PhD

University of Alberta



Dr. Hasan Uludağ has been with the University of Alberta since 1997, currently based at the Department of Chemical & Materials Engineering. He holds joint appoints at the Faculty of Medicine & Dentistry and Faculty of Pharmacy & Pharmaceutical Sciences. Dr. Uludağ is directing interdisciplinary research programs on experimental therapeutics, specifically focusing of designing functional biomaterials to realize the potential of nucleic acid therapies. His research activity is conducted in the context of bone regeneration and anti-cancer therapies. Dr. Uludağ is actively involved in various biomaterials societies around the World and is an elected Fellow of the International Union of Society of Biomaterials Science and Engineering (IUS-BSE). Besides acting as the lead editor for Frontiers in Biomaterials, he is serving on the editorial board of 7 international journals. Dr. Uludağ published ~180 peer-reviewed journal articles and established 2 start-up companies. Dr. Uludağ obtained dual B.Sc. degrees in Biomedical Engineering and Biology from Brown University (Providence, RI) in 1989, specializing in biomedical engineering. He then completed his Ph.D. degree in 1993 at the Department of Chemical Engineering & Applied Chemistry at the University of Toronto. He spent four years in an industrial setting (Genetics Institute Inc.; Boston, MA), where he contributed to development of a tissue engineered bone-inducing BMP device for clinical use.